Bisu, Inc.

Bisu, Inc. is an innovative health technology company that develops at-home wellness testing solutions, empowering users to monitor their health through advanced urine analysis. Founded in 2015 in Chuo-ku, Japan, Bisu, Inc. specializes in providing wellness testing products.

The company has raised a total of USD 3. 2 mn through 7 deals, with its latest funding round, Seed, occurring on October 5, 2021, led by QUAD Investment Management and supported by investors including 15th Rock Ventures, ASICS Ventures, and Pacifico Investments Pte. Ltd. The founding team includes Daniel Maggs and Eli Lyons, with Daniel Maggs serving as the CEO.

Bisu, Inc. focuses on at-home wellness testing solutions, notably the Bisu Body Coach, which offers users the ability to assess health through urine analysis. Utilizing advanced image processing technology, Bisu’s products provide accurate health evaluations. Their flagship product, the Bisu Wellness Test, evaluates critical body markers and is supported by a user-friendly app that delivers real-time insights and personalized recommendations.

The company's offerings reach health-conscious consumers globally, including in the United States, Canada, Australia, and Europe. Bisu generates revenue through direct-to-consumer sales of its wellness testing products, including the Bisu Wellness Test. Customers can purchase individual tests or bundled packages via the company's online platform, while subscription models and promotional campaigns enhance customer engagement. This purchasing approach supports a steady revenue stream while appealing to a diverse clientele interested in health monitoring solutions.

Following the Seed funding round on October 5, 2021, where Bisu, Inc. raised USD 3. 2 mn, the company plans to launch the Bisu Body Coach to market. Additionally, Bisu has established a collaboration with ASICS Corporation to enhance health and fitness services.

These initiatives, supported by the recent funding, aim to expand the company's footprint in the wellness sector.